13F

OKUR ONKURE THERAPEUTICS INC-A

2026Q1 · CUSIP 68277Q105 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
49
Δ holders QoQ
+7
Breadth percentile
Top 37%
Whale holders
20
Δ whales
+1
Inst. holding value
$113M
New positions
17
Closed positions
10
Price momentum (1Q)
+28.3%
Put / Call
0/0

Breadth history (34 quarters)

2024Q4: Δ+50 · h=51 2025Q1: Δ-3 · h=48 2025Q2: Δ+2 · h=50 2025Q3: Δ-8 · h=42 2025Q4: Δ+0 · h=42 2026Q1: Δ+7 · h=49 2024Q4: holders=51 2025Q1: holders=48 2025Q2: holders=50 2025Q3: holders=42 2025Q4: holders=42 2026Q1: holders=49 -50 -25 +0 +25 +50 374654 24Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 1 lit events

Period Percentile Next-1Q return Next-2Q return
2024Q4 Top 9% -61.3% -51.8%

Options Sentiment

Put holders
0
QoQ: 0
Call holders
0
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
EPS (TTM)
$-4.32
EPS YoY
Revenue (TTM)
Revenue YoY
Quarterly Revenue & EPS (4Y)
2021-03-31: EPS -0.35 2021-06-30: EPS -0.43 2025-03-31: EPS -1.19 2025-06-30: EPS -1.14 2025-09-30: EPS -1.09 2025-12-31: EPS -0.98 2026-03-31: EPS -1.11 -1.31 -0.65 0.00 202120252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)